Thursday, October 26, 2006

HemispherX Impresses at Urchin Cap (AMEX: HEB)


Pharma companies always seem to have a buzz in the news but when the investment community takes notice there could be a real story. Hear from Dr. William A. Carter, CEO of HemispherX Biopharma (HEB) about their latest prospects addressing stress disorders.

1 comment:

Tam Richard said...

I am happy to find your distinguished way of writing the post. Now you make it easy for me to understand and implement the concept. Thank you for the post.
french bulldog puppies for sale